A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2004
12/29/2004	EP1194137B1 Naphthoquinone derivatives and their use in the treatment and control of tuberculosis
12/29/2004	EP1189923B1 Aromatic and heterocyclic derivatives of phytosterols and/or phytostanols for use in treating or preventing cardiovascular disease
12/29/2004	EP1177178B1 Heterocyclically substituted benzimidazoles, the production and application thereof
12/29/2004	EP1176140B1 Amide compounds and medicinal use thereof
12/29/2004	EP1171419B1 Biphenyl derivatives as antagonists of the neurokinine-1 receptor
12/29/2004	EP1148059B1 Thiazolopyrimidine compounds, process for the preparation of the same and uses thereof
12/29/2004	EP1146959A4 Method and apparatus for liposome production
12/29/2004	EP1146909A4 Method of treating cancer by restoration of pp32 function
12/29/2004	EP1135123B1 Use of isatin derivatives as ion channel activating agents
12/29/2004	EP1123274B1 Substituted phenyl derivatives, their preparation and use
12/29/2004	EP1123084B1 Use of testosterone esters and/or testosterone for producing bucally applicable bio-adhesive systems with time-released active ingredients
12/29/2004	EP1119551B1 Naphthalenecarboxamides as tachykinin receptor antagonists
12/29/2004	EP1117643B1 New crystal modification n of torasemide
12/29/2004	EP1096937B1 Sustained release ranolazine formulations
12/29/2004	EP1066037B1 Use of indole-2,3-dione-3-oxime derivatives as ampa antagonists
12/29/2004	EP1056729B1 N-[(substituted five-membered di- or triaza diunsaturated ring)carbonyl]guanidine derivatives for the treatment of ischemia
12/29/2004	EP1049474A4 Cannabimimetic lipid amides as useful medications
12/29/2004	EP1045691B1 Statin-carboxyalkylether combinations
12/29/2004	EP1032560B1 Position-4 substituted 2-pyrrolidinone derivatives to reduce the level of extracellular glutamate
12/29/2004	EP1011728B1 Polypropylene containers for prostaglandin products
12/29/2004	EP1009400B1 Combination therapy comprising atorvastatin and an antihypertensive agent
12/29/2004	EP1003745B1 Naphthyridinones for inhibiting protein tyrosine kinase and cell cycle kinase mediated cellular proliferation
12/29/2004	EP0986545B1 Non-steroidal (hetero) cyclically substituted acylanilides with mixed gestagen and androgen activity
12/29/2004	EP0981332B1 Pharmaceutical preparation comprising lyophilized liposomes encapsulating an active principle which is highly insoluble in water, and the process for preparing the said preparation
12/29/2004	EP0971711B1 Anticancer composition comprising a diaminotrifluoromethylpyridine derivative
12/29/2004	EP0967892B1 Additive for use in any energy supplementation, use of a protein hydrolysate to the preparation of energy supplementaton and an energy supplement containing such an additive
12/29/2004	EP0941092B1 Use of nk-1 receptor antagonists for treating major depressive disorders
12/29/2004	EP0934303B1 Compounds useful for inhibition of farnesyl protein transferase
12/29/2004	EP0929545B1 Tricyclic inhibitors of farnesyl protein transferase
12/29/2004	EP0920632B1 Methods for detection of autoimmune diseases
12/29/2004	EP0915701B1 Fast-dissolving galanthamine hydrobromide tablet
12/29/2004	EP0910390B1 Pharmaceutical compositions containing alkylaryl polyether alcohol polymer
12/29/2004	EP0909173B1 Topical administration of certain azaspiranes to prevent or treat skin conditions associated with hyperproliferation of skin cells and/or immunologically mediated disorders
12/29/2004	EP0885211B1 Compounds with a sulfamate group
12/29/2004	EP0874626B1 Use of inhibitors of retinoic acid activity for wound healing
12/29/2004	EP0869958B1 Novel indole-2,3-dione-3-oxime derivatives
12/29/2004	EP0830130B9 Tnf-alpha converting enzyme
12/29/2004	EP0725635B1 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
12/29/2004	EP0722342B1 REGULATION OF bcl-2 GENE EXPRESSION
12/29/2004	CN1559047A DNA providing system
12/29/2004	CN1558946A New strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it
12/29/2004	CN1558911A Synthetic heparin pentasaccharides
12/29/2004	CN1558909A Supermolecular carboplatinum derivatives, their preparation method, and pharmaceutical composition containing them as active ingredient and applications of the composition
12/29/2004	CN1558907A Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
12/29/2004	CN1558906A Method for preparing pyrimidinone compound and pharmaceutically acceptable salts thereof
12/29/2004	CN1558905A Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
12/29/2004	CN1558904A Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same
12/29/2004	CN1558903A Water-soluble phenylpyridazine compounds and compositions containing the same
12/29/2004	CN1558900A Pseudopolymorphic forms of carvedilol
12/29/2004	CN1558899A Spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones
12/29/2004	CN1558898A Antiviral agent
12/29/2004	CN1558897A Antidiabetic agents
12/29/2004	CN1558895A Compositions for treating acne comprising phytandiol amine
12/29/2004	CN1558894A Method for the nitration of phenolic compounds
12/29/2004	CN1558771A Method for treating hepatitis c virus infection in treatment failure patients
12/29/2004	CN1558766A A method of reducing the 'in vivo' cholesterol ester transfer protein mediated transfer of cholesteryl esters between high density lipoproteins (HDL) and low density lipoproteins (LDL)
12/29/2004	CN1558765A Enantiomerically pure opioid diarylmethylpiperzine and methods of using same
12/29/2004	CN1558764A Substituted urea neuropeptide Y Y5 receptor antagonists
12/29/2004	CN1558763A Treatment of hepatitis B virus infection with human monoclonal antibodies
12/29/2004	CN1558762A Novel ligands for the HisB10 Zn2+ sites of the R-state insulin hexamer
12/29/2004	CN1558761A Substituted benzimidazole compounds and their use for the treatment of cancer
12/29/2004	CN1558760A Photodynamic porphyrin antimicrobial agents
12/29/2004	CN1558759A 病毒聚合酶抑制剂 Viral polymerase inhibitors
12/29/2004	CN1558758A Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
12/29/2004	CN1558756A Pharmaceutical compositions for the treatment of urinary disorders
12/29/2004	CN1558755A Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
12/29/2004	CN1558754A Pharmaceutical dosage form with multiple coatings
12/29/2004	CN1558752A Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis and crohn disease
12/29/2004	CN1558751A Method and composition for dry eye treatment
12/29/2004	CN1558750A Topical compositions containing fluid-absorbent solids and adhesive fluids
12/29/2004	CN1558749A Oral composition for treating sensitive teeth
12/29/2004	CN1558719A Nicotinic acid-heterocyclyl-amides and analogous pyrimidine derivatives serving as pesticides
12/29/2004	CN1557955A Diazocines compound and method for preparing it using slime bacteria fermentation and extraction method
12/29/2004	CN1557842A Process for extracting polygonatum polysaccharides, preparing process for medical preparation and use thereof
12/29/2004	CN1557840A Polysaccharides compound preparation and method for preparing the same
12/29/2004	CN1557833A Eplerenone crystalline form exhibiting enhanced dissolution rate
12/29/2004	CN1557830A Process for preparing 20(R)-ginsenoside Rh2
12/29/2004	CN1557826A Method for extracting astragaloside and polysaccharide from traditional Chinese medicine astragalus and its capsule preparation
12/29/2004	CN1557823A L- or D-amino acid-platinum ligand ,preparation method and use thereof
12/29/2004	CN1557815A Isopentenyl xanthone compounds and their use in the preparation of antitumor medicines
12/29/2004	CN1557814A Homocamptoth-ecine compounds, their preparation process and use
12/29/2004	CN1557812A Potassium sodium dehydroandroandrographolide succinates and their preparations
12/29/2004	CN1557811A Phenoxy indenone compounds ,process for preparing same and use thereof
12/29/2004	CN1557808A 3-substituted piperazine triadimenol antifungal compounds and their salts
12/29/2004	CN1557508A Adhesion preventing membrane and its preparing method
12/29/2004	CN1557455A Powder injection of ginko and dipyridamole and its preparing method
12/29/2004	CN1557453A Memory and perception improving pure natural composite preparation and its preparing process
12/29/2004	CN1557414A Orally disintegrating tablet of corydalis rhizome and its preparation
12/29/2004	CN1557413A Sustained and controlled release preparation of corydalis rhizome and its preparation process
12/29/2004	CN1557392A Antitumor medicine
12/29/2004	CN1557388A Poisonous element content decreasing Kawa extracts and its composition and preparing method
12/29/2004	CN1557387A Aromatic turmeric oil extracts and its preparing process and medicinal composition containing the same
12/29/2004	CN1557382A Glucoside compound preparation and its preparing process
12/29/2004	CN1557381A Sore throat relieving preparation
12/29/2004	CN1557352A Novel usage of chicory aqueous extract
12/29/2004	CN1557332A Application of fungus polysaccharide sulfate in the preparation of chronic nephritis and kidney failure treating medicine
12/29/2004	CN1557331A Oral prescription of cytidine triphosphate
12/29/2004	CN1557330A Sustained release medication of clindamycinum
12/29/2004	CN1557329A Medicine composition for treating cardiovascular and cerebrovascular disease and its prepararing method
12/29/2004	CN1557328A Application of 20(R)-ginsenoside Rh2 in pharmacy

1 ... 4843 4844 4845 4846 4847 4848 4849 4850 4851 4852 4853 4854 4855 4856 4857 4858 4859 4860 4861 4862 4863 ... 7860